Hopstem Biotechnology Inc. (hereinafter referred to as "Hopstem"), a company dedicated to the development of induced ...
Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial. The ...
SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
People Science, a leader in decentralized clinical research, today announced the publication of a clinical study conducted with Verb Biotics in Nature Scientific Reports. The peer-reviewed trial ...
13don MSN
Insurance data can help fill gaps between longer medical trials for patients up against the clock
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
News-Medical.Net on MSN
Study finds no safety or efficacy gap between paracetamol and ibuprofen for neonatal PDA
By Priyanjana Pramanik, MSc. A small but rigorous randomized trial suggests paracetamol may be a feasible alternative to ibuprofen for late PDA treatment, while underscoring the need for larger ...
Levee Medical(R) , a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its ...
First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries– Investigator-Initiated (IIT) funded pancreatic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results